Biotricity News

Biotricity and BioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

ORLANDO, FL / ACCESSWIRE / July 12, 2024 / RedChip Companies will air interviews with Biotricity, Inc. (Nasdaq:BTCY) and bioAffinity Technologies, Inc. (Nasdaq:BIAF) on the RedChip Small Stocks, Big

AccesswireJul 12 09:35 ET

Express News | Biotricity Shares Are Trading Higher After the Company Announced That It Expects to Reach a Milestone of Being EBITDA Positive

BenzingaJul 11 12:01 ET

Express News | Biotricity Inc - Expects to Reach Ebitda Positive Before End of Calendar 2024

ReutersJul 11 07:33 ET

Express News | Biotricity Inc - Accelerated Timeline to Achieving Ebitda Positive

ReutersJul 11 07:32 ET

Biotricity Announces Accelerated Path to EBITDA Positive

REDWOOD CITY, CA / ACCESSWIRE / July 11, 2024 / Biotricity Inc. (NASDAQ:BTCY), a Technology-as-a-Service (TaaS) company operating in the remote cardiac monitor sector of consumer healthcare, today

AccesswireJul 11 07:00 ET

Biotricity Adds 60-Site, Multi-State Hospital Cardiac Monitoring Pilot Program

REDWOOD CITY, CA / ACCESSWIRE / July 10, 2024 / Biotricity Inc. (Nasdaq:BTCY), a Technology-as-a-Service (TaaS) company operating in the remote cardiac monitor sector of consumer healthcare, today

AccesswireJul 10 09:20 ET

Biotricity | 10-K/A: Annual report (Amendment)

SEC announcementJun 28 13:14 ET · Announcements

Biotricity Launches HeartSecure: Immediate, At-Home Cardiac Screening Now Available

Democratizing cardiac health with convenient, rapid, and reliable results REDWOOD CITY, CA / ACCESSWIRE / June 28, 2024 / Biotricity Inc. (NASDAQ:BTCY), a forerunning Technology-as-a-Service (TaaS) co

AccesswireJun 28 07:30 ET

Earnings Call: Biotricity Reports Growth and Expansion in FY 2024

InvestingJun 28 06:06 ET

Biotricity, Inc. (BTCY) Q4 2024 Earnings Call Transcript

Biotricity, Inc. (BTCY) Q4 2024 Earnings Call Transcript

Earnings Call TranscriptsJun 27 18:40 ET

Biotricity GAAP EPS of -$0.47, Revenue of $3.2M In-line

Seeking AlphaJun 27 09:45 ET

Express News | Biotricity Q4 Revenue $3.2M, Up 15.9% YoY, EPS $(0.47)

BenzingaJun 27 08:19 ET

Express News | Biotricity Q4 Gross Margin 71.5%

ReutersJun 27 08:16 ET

Express News | Biotricity Q4 EPS USD -0.47

ReutersJun 27 08:16 ET

Express News | Biotricity Q4 Net Income USD -4.4 Million

ReutersJun 27 08:16 ET

Biotricity Reports Strong Results With Revenue Growth, Continued Margin Improvement, and Reduced Operating Expenses for Fiscal Year 2024, Accelerating the Company's Path to Profitability

FY24 revenue up 25.2% YOYFY24 margins improved 1280 basis points to 69.3%, from 56.5% in the prior year; Q4-FY24 margins improved to 71.5%; margin expansion forecasted to continueFY24 operating expens

AccesswireJun 27 08:15 ET

Biotricity | 10-K: Annual report

SEC announcementJun 27 06:03 ET · Announcements

Biotricity to Host Fourth Quarter and Fiscal Year 2024 Financial Results and Business Update Call on June 27

REDWOOD CITY, CA / ACCESSWIRE / June 26, 2024 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a Technology-as-a-Service (TaaS) company operating in the remote cardiac monitor sector o

AccesswireJun 26 16:15 ET

Biotricity Launches Direct-to-Consumer Heart Health Screening Service, HeartSecure, Making Heart Health Services Accessible in Response to the #1 Global Killer, Poising Company to Access the Growing Home Diagnostics Market

Biotricity Inc. (NASDAQ:BTCY), a forerunning Technology-as-a-Service (TaaS) company committed to disrupting the healthcare industry with cutting-edge medical and consumer diagnostic solutions, today announces the highly anticipated launch of its direct-to-consumer heart health screening program, HeartSecure.

BiotricityJun 12 00:00 ET

Express News | Biotricity Sees Year-End Revenue Growth To Exceed 24% YoY; Loss From Operations To Decrease Over 40% YoY; Margins To Improve Over 10% YoY

BenzingaJun 6 09:21 ET